Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...

Dr. Tunde Popoola belongs to the latter category, a rare breed of leader who saw what others couldn’t see: that Nigeria’s economic potential was locked behind walls of information asymmetry, and that ...

There are builders who construct edifices, and then there are visionaries who architect systems that transform entire nations. Dr.

Born out of a partnership between the New Jersey Community Resource Center (NJ CRC) and the New Jersey Department of Health ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...

Macronix International has expanded its MXSMIO flash memory portfolio to include devices that meet the highest automotive ...

The Video Electronics Standards Association (VESA®) today announced the release of version 1.1 of its DisplayPort™ Automotive ...

Exelixis, Inc. and Natera , a global leader in cell-free DNA and precision medicine, today announced their collaboration on the planned Exelixis-sponsored STELLAR-316 trial. This randomized phase 3 ...

High-Performance MXSMIO Flash Devices Now Compliant with ISO 26262 ASIL D StandardHSINCHU, Jan. 5, 2026 /PRNewswire/ -- Macronix International Co., Ltd.